| 2.54 -0.155 (-5.75%) | 04-07 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.18 | 1-year : | 3.72 |
| Resists | First : | 2.73 | Second : | 3.18 |
| Pivot price | 2.24  |
|||
| Supports | First : | 2.21 | Second : | 1.88 |
| MAs | MA(5) : | 2.52 |
MA(20) : | 2.28 |
| MA(100) : | 2.48 |
MA(250) : | 4.8 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 90.6 |
D(3) : | 88.9 |
| RSI | RSI(14): 59.1 |
|||
| 52-week | High : | 9.8 | Low : | 1.84 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ACH ] has closed below upper band by 18.5%. Bollinger Bands are 3.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.73 - 2.74 | 2.74 - 2.75 |
| Low: | 2.47 - 2.49 | 2.49 - 2.5 |
| Close: | 2.52 - 2.54 | 2.54 - 2.56 |
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
Thu, 26 Mar 2026
Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment - Stock Titan
Fri, 13 Mar 2026
Is the Options Market Predicting a Spike in Accendra Health Stock? - Yahoo Finance
Fri, 20 Feb 2026
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Thu, 19 Feb 2026
Accendra Health Posts 2025 Results, Guides 2026 Outlook - tipranks.com
Thu, 19 Feb 2026
Accendra Health Reports Fourth Quarter 2025 Financial Results - businesswire.com
Fri, 09 Jan 2026
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 76 (M) |
| Shares Float | 60 (M) |
| Held by Insiders | 3.6 (%) |
| Held by Institutions | 93.9 (%) |
| Shares Short | 8,190 (K) |
| Shares Short P.Month | 8,300 (K) |
| EPS | -1.35 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -6.04 |
| Profit Margin | -39.9 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | -163.8 % |
| Qtrly Rev. Growth | -73.7 % |
| Gross Profit (p.s.) | 16.87 |
| Sales Per Share | 36.1 |
| EBITDA (p.s.) | 4.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -102 (M) |
| Levered Free Cash Flow | 672 (M) |
| PE Ratio | -1.9 |
| PEG Ratio | 0 |
| Price to Book value | -0.43 |
| Price to Sales | 0.07 |
| Price to Cash Flow | -1.91 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|